RedHill Biopharma Ltd (RDHL)

[midastouch017]

Wall Street analysts forecast that Redhill Biopharma Ltd. (NASDAQ:RDHL) will announce sales of $1.27 million for the current quarter, Zacks reports. Two analysts have provided estimates for Redhill Biopharma’s earnings. The highest sales estimate is $1.64 million and the lowest is $900,000.00. The firm is expected to announce its next quarterly earnings report on Monday, November 13th.
According to Zacks, analysts expect that Redhill Biopharma will report full year sales of $1.27 million for the current financial year, with estimates ranging from $2.78 million to $4.69 million. For the next financial year, analysts expect that the business will post sales of $13.92 million per share, with estimates ranging from $11.01 million to $16.83 million. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that that provide coverage for Redhill Biopharma.

https://stocknewstimes.com/2017/08/24/1-27-million-in-sales-expected-for-redhill-biopharma-ltd-rdhl-this-quarter.html